Award

University of Washington Medical Center BL1933256U-054

PHARMACEUTICALS FOR HUMAN USE SALES TAX EXEMPT LIMITED DISTRIBUTION MEDICATIONS

Recipient

BIOGEN DIRECT

Award Amount

$23,600.00

Ceiling

$23,600.00

Awarded

June 15, 2022

Identifier

BL1933256U-054

The University of Washington Medical Center, a public hospital in Washington state, issued a purchase order on June 15, 2022, to Biogen Direct for pharmaceuticals intended for human use, specifically sales tax exempt limited distribution medications. The order amount was $23,600.00, and the procurement involved a single line item with a quantity of one at a unit price of approximately $23,600.85. The purchase was for pharmaceuticals categorized under medical supplies, and the contract appears to be a single-transaction order. The award is part of the hospital's procurement activities for medical supplies and pharmaceuticals, with no indication of a multi-year or blanket arrangement.

Description

PHARMACEUTICALS FOR HUMAN USE SALES TAX EXEMPT LIMITED DISTRIBUTION MEDICATIONS